The use of hydroxycarbamide in children with sickle cell anemia
Sahel medical journal (Print)
; 21(4): 189-193, 2018. tab
Article
em En
| AIM
| ID: biblio-1271688
Biblioteca responsável:
CG1.1
ABSTRACT
Background:
Although hydroxycarbamide (hydroxyurea [HU]) has been in use for decades in both adults and child populations with sickle cell disease (SCD), its reported use has remained low in Africa and Nigeria where the largest number of SCD patients reside. Availability, cost, and concerns about safety and efficacy are some of the challenges to its use.Objectives:
This study highlights the experience of using HU for children with sickle cell anemia in Ahmadu Bello University Teaching Hospital, Zaria.Materials andMethods:
A descriptive, retrospective observational study of children is presented. Demographic, clinical, and laboratory features of children on HU, the indications for therapy and adverse clinical events encountered were analyzed.Results:
A total of 165 children were treated with HU over a 4year period, their ages ranging between 0.9 and 17 years. A total of 85 (47.5%) had HU for >12 months, while 61 (34.1%) were on treatment <11 months, while 19 (10.2%) were lost to followup. There was a significant increase in the weight, height, fetal hemoglobin, mean corpuscular volume, and a significant reduction in white cell counts; with no differences in the packed cell volume, hemoglobin concentration, creatinine, alanine transaminase, and bilirubin levels. Adverse events and/or comorbidities were reported in 48 (56.5%) patients, while one patient discontinued treatment because of skin rash.Conclusion:
This study highlights the increased utilization of HU among children in an African region, the observed clinical events,and laboratory parameters. The benefits are demonstrable, and the drugrelated organ toxicities appear minimal
Buscar no Google
Assunto principal:
Hidroxiureia
/
Anemia Falciforme
/
Nigéria
Tipo de estudo:
Observational_studies
País/Região como assunto:
Africa
Idioma:
En
Revista:
Sahel medical journal (Print)
Ano de publicação:
2018
Tipo de documento:
Article